Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion | Zendy

Chandima Divithotawela | Zendy; Marcelo Cypel | Zendy; Tereza Martinu | Zendy; L.G. Singer | Zendy; Matthew Binnie | Zendy; ChungWai Chow | Zendy; Cecilia Chaparro | Zendy; Thomas K. Waddell | Zendy; Marc de Perrot | Zendy; Andrew Pierre | Zendy; Kazuhiro Yasufuku | Zendy; Jonathan Yeung | Zendy; Laura Donahoe | Zendy; Shaf Keshavjee | Zendy; Jussi Tikkanen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion

Author(s) -

Chandima Divithotawela,

Marcelo Cypel,

Tereza Martinu,

L.G. Singer,

Matthew Binnie,

ChungWai Chow,

Cecilia Chaparro,

Thomas K. Waddell,

Marc de Perrot,

Andrew Pierre,

Kazuhiro Yasufuku,

Jonathan Yeung,

Laura Donahoe,

Shaf Keshavjee,

Jussi Tikkanen

Publication year - 2019

Publication title -

jama surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.757

H-Index - 176

eISSN - 2168-6262

pISSN - 2168-6254

DOI - 10.1001/jamasurg.2019.4079

Subject(s) - medicine , interquartile range , lung transplantation , lung , single center , retrospective cohort study , surgery

The mortality rate for individuals on the wait list for lung transplant is 15% to 25%, and still only 20% of lungs from multiorgan donors are used for lung transplant. The lung donor pool may be increased by assessing and reconditioning high-risk extended criteria donor lungs with ex vivo lung perfusion (EVLP), with similar short-term outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research